Philip Morris shares soar on strong third quarter
Recasts paragraph 1 on shares; adds background in paragraph 2; CEO quote in paragraph 5
Oct 22 (Reuters) -Philip Morris International's (PMI) <PM.N> shares hit record highs on Tuesday after the cigarette maker raised its annual profit forecast and beat third-quarter estimates thanks to higher prices and strong demand for its smoking alternatives.
PMI has invested billions of dollars in developing substitutes for cigarettes as health-conscious consumers switch to smoking alternatives in some markets, including its IQOS heated tobacco device and ZYN nicotine pouches, which are now a key focus for investors.
U.S. ZYN shipments in the quarter grew 41.4% over the prior-year period, rebounding after supply constraints curtailed rapid growth.The Marlboro maker has been investing to expand production capacity for ZYN, in an effort to meet strong demand.
The company's flagship heated tobacco device, IQOS, also saw strong growth in regions such as Japan, Europe and Indonesia, reassuring investors after volumes lagged expectations in the past.
"We delivered exceptionally strong performance, with record quarterly net revenues and earnings per share," said Chief Executive Officer Jacek Olczak, adding IQOS growth had also accelerated.
PMI's shares rose 9%, and remained almost 8% higher at 11.43 a.m. (1543 GMT) in New York trading.
The company also enjoyed higher shipment volumes for cigarettes, with higher pricing also driving a 5.2% increase in revenues from its combustible tobacco business.
PMI raised its forecast for 2024 adjusted earnings per share, excluding currency, to between$6.85 and $6.91, compared with its prior range of $6.67 to $6.79.
It reported revenue of $9.91 billion for the third quarter, versus analysts' estimatesof $9.69 billion, according to data compiled by LSEG.
Its quarterly adjusted profit of $1.91 per share also beat estimates of $1.82 per share.
Last week, Philip Morris said it, along with peers British American Tobacco BATS.L and Japan Tobacco 2914.T, would pay C$32.5 billion ($23.6 billion) to settle long-running health-related lawsuitsin Canada.
Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Shilpi Majumdar and Sharon Singleton
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
